Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2020

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Point-of-Care (POC) Analyzers Overview

3 Products under Development
3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory
3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date

4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies
4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development

5 Point-of-Care (POC) Analyzers Companies and Product Overview
5.1 Abingdon Health Ltd Company Overview
5.2 Access Bio Inc Company Overview
5.3 Acrongenomics Inc (Inactive) Company Overview
5.4 AgPlus Diagnostics LTD Company Overview
5.5 Akers Biosciences Inc Company Overview
5.6 Akonni Biosystems Inc Company Overview
5.7 Alere Inc Company Overview
5.8 Analytical Diagnostic Solutions Inc Company Overview
5.9 ApoCell Inc Company Overview
5.10 Aptatek BioSciences Inc Company Overview
5.11 Atonomics A/S Company Overview
5.12 Binghampton University Company Overview
5.13 Bio-AMD Inc Company Overview
5.14 BioMedomics Inc Company Overview
5.15 Biopico Systems Inc Company Overview
5.16 Biosensia Ltd Company Overview
5.17 Boston University Company Overview
5.18 BreviTest Technologies LLC Company Overview
5.19 Brigham and Women's Hospital Company Overview
5.20 Calmark Sweden AB Company Overview
5.21 Canon USA Inc Company Overview
5.22 CardioGenics Inc Company Overview
5.23 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Company Overview
5.24 ChipCare Corp Company Overview
5.25 City, University of London Company Overview
5.26 Co-Diagnostics Inc Company Overview
5.27 Cornell University Company Overview
5.28 Cutting Edge Medical Devices Limited Company Overview
5.29 Diagnostics For All Inc Company Overview
5.30 Duke University Company Overview
5.31 EKF Diagnostics Holdings Plc Company Overview
5.32 Endeavor Sciences Inc Company Overview
5.33 ExcitePCR Corp Company Overview
5.34 Exosome Diagnostics Inc Company Overview
5.35 Fawkes Biotechnology LLC Company Overview
5.36 First Light Diagnostics Inc Company Overview
5.37 Florida International University Company Overview
5.38 Future Diagnostics Solutions BV Company Overview
5.39 Giner Inc Company Overview
5.40 GlucoSentient Inc Company Overview
5.41 Indian Institute of Science Company Overview
5.42 Indian Institute of Technology Chennai Company Overview
5.43 Intelligent Optical Systems, Inc. Company Overview
5.44 LightDeck Diagnostics Inc Company Overview
5.45 Louisiana State University Company Overview
5.46 Lucendi Inc Company Overview
5.47 Masaryk University Company Overview
5.48 Maxygen-mobile DNA tests Company Overview
5.49 McKesson Corp Company Overview
5.50 MML Ltd Company Overview
5.51 MobioSense Inc Company Overview
5.52 MW Diagnostics Ltd Company Overview
5.53 Nalia Systems Ltd Company Overview
5.54 Newcastle University Company Overview
5.55 Nikkiso Co Ltd Company Overview
5.56 Novel Microdevices LLC Company Overview
5.57 Ohmx Corp Company Overview
5.58 OncoGenesis Company Overview
5.59 Ontera Inc Company Overview
5.60 Optolane Technologies Inc Company Overview
5.61 Pacific Nanoscience, Inc. Company Overview
5.62 POC Medical Systems Inc Company Overview
5.63 ProciseDx LLC Company Overview
5.64 Quanterix Corp Company Overview
5.65 Qvella Corp Company Overview
5.66 Radisens Diagnostics Ltd Company Overview
5.67 Raman Diagnostics Ltd (Inactive) Company Overview
5.68 RMIT University Company Overview
5.69 Scanogen Inc Company Overview
5.70 SeLux Diagnostics Inc Company Overview
5.71 SenGenix Inc Company Overview
5.72 StemTek Therapeutics SL Company Overview
5.73 Thermal Gradient Inc Company Overview
5.74 Trinity Biotech Plc Company Overview
5.75 University of Calgary Company Overview
5.76 University of California Berkeley Company Overview
5.77 University of Glasgow Company Overview
5.78 University of Illinois at Chicago Company Overview
5.79 University of Illinois at Urbana-Champaign Company Overview
5.80 Wellstat Diagnostics LLC Company Overview

6 Point-of-Care (POC) Analyzers- Recent Developments
6.1 Mar 23, 2020: McKesson announces executive vice president and chief strategy and business development officer to step down
6.2 Mar 10, 2020: Instrumentation Laboratory launches new GEM Premier ChemSTAT Testing System with iQM In the US
6.3 Feb 26, 2020: bioMerieux – 2019 financial results
6.4 Feb 19, 2020: Sphingotec’s Biomarker penKid shows best representation of true glomerular filtration rate and has utility in patients with severe burns two studies show
6.5 Feb 04, 2020: McKesson reports fiscal 2020 third quarter results
6.6 Jan 28, 2020: Updated timetable for the clinical trial at Sodersjukhuset
6.7 Jan 15, 2020: The Calmark Neo diagnostics platform will be showcased at the international healthcare and medical exhibition Arab Health
6.8 Jan 14, 2020: Hitado becomes Nexus IB10 distributor for sphingotec in Germany and Switzerland
6.9 Jan 13, 2020: Sphingotec launches IVD test for kidney function biomarker penKid on Nexus IB10 POCT Platform
6.10 Jan 07, 2020: BioDirection appoints Dr. Jean-Luc Boulnois to its Board of Directors
6.11 Dec 23, 2019: Significant milestone reached – product tested on patient
6.12 Dec 23, 2019: Calmark’s product Neo-Bilirubin will obtain CE Mark approval in January 2020
6.13 Dec 20, 2019: Sphingotec's biomarker Penkid predicts septic acute kidney injury at time of admission to emergency department
6.14 Dec 12, 2019: McKesson selected by Department of Veterans Affairs as prime pharmaceutical provider
6.15 Dec 09, 2019: McKesson appoints Nancy Flores as executive vice president, chief information and chief technology officer
6.16 Dec 03, 2019: First Light Diagnostics to present at New England Venture Summit
6.17 Dec 03, 2019: OPTOLANE chooses Trustonic to protect new connected medical diagnostic devices

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory
Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Table 5: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
Table 6: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Table 7: Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Next Generation Multiplex POC Biosensor Device - Product Status
Table 9: Next Generation Multiplex POC Biosensor Device - Product Description
Table 10: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: All-in-One Sensor - Product Status
Table 12: All-in-One Sensor - Product Description
Table 13: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 14: BioLED Device - Diabetes Management - Product Status
Table 15: BioLED Device - Diabetes Management - Product Description
Table 16: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 17: AgPlus Diagnostic System - Product Status
Table 18: AgPlus Diagnostic System - Product Description
Table 19: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: minDNAnalyzer - Product Status
Table 21: minDNAnalyzer - Product Description
Table 22: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: TruDx 2000 Platform - Product Status
Table 24: TruDx 2000 Platform - Product Description
Table 25: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Clondiag HIV Molecular Device - Product Status
Table 27: Clondiag HIV Molecular Device - Product Description
Table 28: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: BiliNow - Product Status
Table 30: BiliNow - Product Description
Table 31: PKU Now - Product Status
Table 32: PKU Now - Product Description
Table 33: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: ApoStream System - Product Status
Table 35: ApoStream System - Product Description
Table 36: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Point Of Care Diagnostic Device - Phenylketonuria - Product Status
Table 38: Point Of Care Diagnostic Device - Phenylketonuria - Product Description
Table 39: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Atolyzer PoC - Product Status
Table 41: Atolyzer PoC - Product Description
Table 42: Binghampton University Pipeline Products & Ongoing Clinical Trials Overview
Table 43: U-PAC - Product Status
Table 44: U-PAC - Product Description
Table 45: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Magnetic Immunoassay Detection System - Product Status
Table 47: Magnetic Immunoassay Detection System - Product Description
Table 48: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: TR-LFIA Diagnostic Analyzer - Product Status
Table 50: TR-LFIA Diagnostic Analyzer - Product Description

List of Figures
Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory
Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date